unknown
Stage
2012
Founded
1
Investors
About
Ability Pharma is a clinical-stage biopharmaceutical company focused on developing innovative therapies for unmet medical needs in oncology. Their lead compound, ABTL0812, is an anti-cancer drug currently in Phase 2b clinical trials for pancreatic cancer and Phase 2a for endometrial cancer.
Explore Ability Pharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.